DexCom (DXCM) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.35 +1.61%
EPS Growth %: +9.8%
Financial Fact:
Research and development: 43.9M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +9.8%
Financial Fact:
Research and development: 43.9M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $93.2 million versus the consensus estimate of $84.81 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
